Long-circulating thiolated chitosan nanoparticles of nintedanib with N-acetyl cysteine for treating idiopathic pulmonary fibrosis: In vitro assessment of cytotoxicity, antioxidant, and antifibrotic potential-Reference-Cited by-同舟云学术

Long-circulating thiolated chitosan nanoparticles of nintedanib with N-acetyl cysteine for treating idiopathic pulmonary fibrosis: In vitro assessment of cytotoxicity, antioxidant, and antifibrotic potential

Published:2023-09 Issue: Volume:644 Page:123322
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Singh Sanskriti,Wairkar Sarika^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study;Ajun;Carbohydr. Polym.,2009

2. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system;Arias;Biomacromolecules,2011

3. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles;Banerjee;Int. J. Pharm.,2002

4. Chromium(VI) forms thiolate complexes with γ-glutamylcysteine, N-acetylcysteine, cysteine, and the methyl ester of N-acetylcysteine;Brauer;Inorg. Chem.,1996

5. Features of apoptotic cells measured by flow cytometry;Darzynkiewicz;Cytometry,1992

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiolated chitosan nanoparticles encapsulated nisin and selenium: antimicrobial/antibiofilm/anti-attachment/immunomodulatory multi-functional agent;BMC Microbiology;2024-07-12

2. Flavonoids for treating pulmonary fibrosis: Present status and future prospects;Phytotherapy Research;2024-07-10

3. Advanced Delivery Strategies of Nintedanib for Lung Disorders and Beyond: A Comprehensive Review;AAPS PharmSciTech;2024-07-01

4. Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment – Evidence in disease-relevant in-vitro models;Journal of Drug Delivery Science and Technology;2024-05

5. Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-04-08